Diana Prieto-Peña, Mónica Calderón-Goercke, Alfredo Adán, Lillian Chamorro-López, Olga Maíz-Alonso, Juan R De Dios-Jiménez Aberásturi, Raúl Veroz, Soledad Blanco, José M Martín-Santos, Francisco Navarro, Adela Gallego, Senén González-Suárez, Arantxa Conesa, Andrea García-Valle, Miguel Cordero-Coma, Nieves Pardiñas-Barón, Rosalía Demetrio, Vanesa Calvo-Río, Víctor M Martínez-Taboada, Santos Castañeda, José L Hernández, Miguel A González-Gay, Ricardo Blanco
OBJECTIVES: Clinicians often face the challenge of providing effective and safe therapy for pregnant women with uveitis. Certolizumab pegol (CZP) differs from other anti-TNFα agents due to its limited placental transfer. In this study we assessed the efficacy of CZP in pregnant women with uveitis. We also provided information on outcomes of pregnant women and neonates exposed to CZP. METHODS: We carried out a multicentre study of women with uveitis who received CZP during pregnancy and their neonates...
January 2021: Clinical and Experimental Rheumatology